Bicara Therapeutics Inc. Common Stock Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 6.96 M | $90.64 M | 0.00% | 12.77% |
FMR LLC | 05/12/2025 | 3.61 M | $47.06 M | 70.59% | 6.63% |
SIREN, L.L.C. | 05/23/2025 | 3.27 M | $42.57 M | -0.18% | 6.00% |
TPG GP A, LLC | 05/15/2025 | 3.01 M | $39.23 M | 0.00% | 5.53% |
VESTAL POINT CAPITAL, LP | 05/15/2025 | 2.77 M | $36.08 M | 290.00% | 5.08% |
OMEGA FUND MANAGEMENT, LLC | 05/15/2025 | 2.20 M | $28.73 M | 0.00% | 4.05% |
BRAIDWELL LP | 05/15/2025 | 2.16 M | $28.18 M | 8.10% | 3.97% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 2.00 M | $26.06 M | 0.00% | 3.67% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 1.80 M | $23.43 M | 16.21% | 3.30% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 1.39 M | $18.17 M | 84.00% | 2.56% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 1.34 M | $18.01 M | 55.55% | 2.47% |
BLACKROCK, INC. | 05/02/2025 | 1.34 M | $17.49 M | 6.37% | 2.46% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 1.18 M | $15.41 M | -45.62% | 2.17% |
MORGAN STANLEY | 05/15/2025 | 1.15 M | $15.01 M | 185.95% | 2.12% |
VANGUARD GROUP INC | 05/09/2025 | 1.09 M | $14.22 M | 0.05% | 2.00% |
BLACKSTONE INC. | 05/15/2025 | 1.03 M | $13.40 M | 12.62% | 1.89% |
FIL LTD | 05/12/2025 | 1.01 M | $13.21 M | 0.00% | 1.86% |
FORESITE CAPITAL MANAGEMENT VI LLC | 05/15/2025 | 950.00 K | $12.38 M | 0.00% | 1.74% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 833.33 K | $10.86 M | 0.00% | 1.53% |
05/19/2025 | 643.38 K | $8.38 M | 0.00% | 1.18% | |
AISLING CAPITAL MANAGEMENT LP | 05/13/2025 | 568.92 K | $7.41 M | 0.00% | 1.04% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 491.65 K | $6.41 M | 5.36% | 0.90% |
STATE STREET CORP | 05/15/2025 | 370.13 K | $4.82 M | 21.46% | 0.68% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 365.96 K | $4.77 M | 100.00% | 0.67% |
WOODLINE PARTNERS LP | 05/15/2025 | 348.69 K | $4.54 M | 26.48% | 0.64% |
ORBIMED ADVISORS LLC | 05/15/2025 | 298.30 K | $3.89 M | 0.00% | 0.55% |
NAPEAN TRADING & INVESTMENT CO (SINGAPORE) PTE LTD | 05/15/2025 | 275.94 K | $3.60 M | 100.00% | 0.51% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 212.00 K | $2.76 M | 100.95% | 0.39% |
NORTHERN TRUST CORP | 05/13/2025 | 154.21 K | $2.01 M | -3.04% | 0.28% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 153.00 K | $1.99 M | -2.41% | 0.28% |
TD ASSET MANAGEMENT INC | 05/07/2025 | 130.94 K | $1.71 M | 27.84% | 0.24% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 125.70 K | $1.64 M | -30.07% | 0.23% |
HEALTHINVEST PARTNERS AB | 05/05/2025 | 119.83 K | $1.56 M | 100.00% | 0.22% |
DEUTSCHE BANK AG\ | 05/09/2025 | 111.38 K | $1.45 M | -0.97% | 0.20% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 68.56 K | $893.35 K | 135.30% | 0.13% |
UBS GROUP AG | 05/13/2025 | 65.85 K | $858.08 K | -67.14% | 0.12% |
STEMPOINT CAPITAL LP | 05/15/2025 | 47.08 K | $613.43 K | 100.00% | 0.09% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 42.19 K | $549.76 K | 4.78% | 0.08% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 05/13/2025 | 41.66 K | $558.24 K | 100.00% | 0.08% |
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 05/07/2025 | 38.04 K | $495.60 K | 0.00% | 0.07% |
VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 34.43 K | $448.62 K | 100.00% | 0.06% |
JEFFERIES FINANCIAL GROUP INC. | 05/08/2025 | 30.60 K | $398.73 K | 100.00% | 0.06% |
XTX TOPCO LTD | 05/08/2025 | 28.45 K | $370.74 K | 4.09% | 0.05% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 25.65 K | $334.19 K | -93.35% | 0.05% |
05/12/2025 | 25.03 K | $326.12 K | 100.00% | 0.05% | |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 24.90 K | $324.47 K | 100.00% | 0.05% |
RHUMBLINE ADVISERS | 05/29/2025 | 23.02 K | $299.92 K | 21.10% | 0.04% |
JPMORGAN CHASE & CO | 05/12/2025 | 21.79 K | $283.98 K | -66.34% | 0.04% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 21.52 K | $280.37 K | 1,075.79% | 0.04% |
BARCLAYS PLC | 05/15/2025 | 20.27 K | $264.00 K | -32.67% | 0.04% |
Bicara Therapeutics Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 98 institutional investors and hedge funds held shares of Bicara Therapeutics Inc. Common Stock. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 6.96 M
FMR LLC: 3.61 M
Siren, L.L.C.: 3.27 M
TPG GP A, LLC: 3.01 M
Vestal Point Capital, LP: 2.77 M
Omega Fund Management, LLC: 2.2 M
81.29% of Bicara Therapeutics Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 43.82 M shares in the last 24 months. This purchase volume represents approximately $401.80 M in transactions.